SCHEMBL722286

SCHEMBL722286

CCC(=O)OCC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.43
ALDH1A1 P00352 6/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
BLM P54132 1/20 0.39
WRN Q14191 1/20 0.39
HIF1A Q16665 1/20 0.39
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
LMNA P02545 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TRPA1 O75762 1/20 0.33
KMT2A Q03164 1/20 0.33
MIF P14174 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
FFAR3 O14843 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29626584 0.97 NAAA (0.41) NAAAALDH1A1CYP2C19CYP1A2HPGD
Ethylene Glycol SCHEMBL27980989 0.93 NAAA (0.39) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL14727861 0.87 NAAA (0.35) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL15281013 0.84 LMNA (0.45) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL14472846 0.84 NAAA (0.43) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL4450857 0.82 NAAA (0.41) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL12956462 0.81 NAAA (0.38) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL1326486 0.81 NAAA (0.44) NAAAALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL722025 0.81 GAA (0.50) CYP2C19GAAMGAMSIMGAM2
SCHEMBL2485813 0.81 ADRA2A (0.42) ALDH1A1CYP2C19CYP1A2BLMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109119598-B Non-aqueous electrolyte and secondary battery 微宏动力系统(湖州)有限公司 2021-09-21 CN claimed
CN-107666011-B Non-aqueous electrolyte and non-aqueous electrolyte secondary battery 微宏动力系统(湖州)有限公司 2020-07-28 CN claimed
CN-109665961-A A kind of preparation method of 3- (2,2- dimethyl propylene oxygroup) propionic acid -2,2- dimethyl propyl ester 韶关市合众化工有限公司 2019-04-23 CN claimed
WO-2011003959-A1 ELECTROLYTE MIXTURE AND THE USE THEREOF CONTINENTAL AUTOMOTIVE GMBH (DE) 2011-01-13 WO claimed
CN-115175735-B Antiviral compounds 吉利德科学公司 2025-03-04 CN disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
CN-118076767-A Method and formulation for producing an optical metal oxide layer 默克专利有限公司 2024-05-24 CN disclosed
US-20230322704-A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN GLOBAL BLOOD THERAPEUTICS, INC. 2023-10-12 US disclosed
US-20230322793-A1 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating Influenza NOVARTIS AG (CH) 2023-10-12 US disclosed
CN-116617233-A Methods of treating arenaviridae and coronaviridae viral infections 吉利德科学公司 2023-08-22 CN disclosed
US-20230212195-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-07-06 US disclosed
WO-2023057401-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2023-04-13 WO disclosed
EP-0721454-A1 NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST J. URIACH & CIA. S.A. (ES) 1996-07-17 EP disclosed
WO-1996004273-A1 NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST J. URIACH & CIA, S.A. (ES) 1996-02-15 WO disclosed
EP-0409291-B1 Thermoplastic resin composition JAPAN SYNTHETIC RUBBER CO LTD (JP) 1996-02-14 EP disclosed
EP-0317262-B1 Transparent resin material JAPAN SYNTHETIC RUBBER CO LTD (JP) 1996-01-31 EP disclosed
US-5164469-A Substrate for optical disks, ring opening polymerization of tetracyclododecene derivatives JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1992-11-17 US disclosed
US-5053471-A Methathesis ring opening polymerization of polar substituted norbornenes or octahydromethanonphthalenes; optics JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-10-01 US disclosed
EP-0409291-A2 Thermoplastic resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-01-23 EP disclosed
EP-0317262-A2 Transparent resin material JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1989-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322704-A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN HBG2, HBG1, HBB NAAA 4443/4885ALDH1A1 1089/4885CYP2C19 493/4885
US-20230212195-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF DNPEP, DHPS, NPEPPS NAAA 2072/4885ALDH1A1 2862/4885CYP2C19 692/4885
US-20230322793-A1 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating Influenza MAVS, ZC3HAV1, EIF2AK2 NAAA 4601/4885ALDH1A1 2395/4885CYP2C19 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.